Correction: Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420659/
https://www.ncbi.nlm.nih.gov/pubmed/34479928
http://dx.doi.org/10.1136/jitc-2021-003000corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420659/
https://www.ncbi.nlm.nih.gov/pubmed/34479928
http://dx.doi.org/10.1136/jitc-2021-003000corr1

Ejemplares similares